MSEGX
Price
$59.51
Change
-$0.30 (-0.50%)
Updated
Jun 16 closing price
Net Assets
3.57B
RGAFX
Price
$87.37
Change
-$0.79 (-0.90%)
Updated
Jun 16 closing price
Net Assets
360.63B
Interact to see
Advertisement

MSEGX vs RGAFX

Header iconMSEGX vs RGAFX Comparison
Open Charts MSEGX vs RGAFXBanner chart's image
MSEGX vs RGAFX Comparison Chart in %
View a ticker or compare two or three
VS
MSEGX vs. RGAFX commentary
Jun 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEGX is a Hold and RGAFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 361B vs. MSEGX (3.57B). RGAFX pays higher dividends than MSEGX: RGAFX (0.46) vs MSEGX (0.00). MSEGX was incepted earlier than RGAFX: MSEGX (30 years) vs RGAFX (24 years). MSEGX (0.89) is less costly to investors than RGAFX (0.34). MSEGX is a more actively managed with annual turnover of: 53.00 vs. RGAFX (32.00). RGAFX has a lower initial minimum investment than MSEGX: RGAFX (250) vs MSEGX (1000). RGAFX annual gain was more profitable for investors over the last year : 10.95 vs. MSEGX (4.78). RGAFX return over 5 years is better than : 21.64 vs. MSEGX (-34.71).
MSEGXRGAFXMSEGX / RGAFX
Total Expense Ratio0.890.34262%
Annual Report Gross Expense Ratio0.890.34262%
Fund Existence30 years24 years-
Gain YTD-4.1358.642-48%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.57B361B1%
Annual Yield % from dividends0.000.46-
Returns for 1 year4.7810.9544%
Returns for 3 years97.4647.91203%
Returns for 5 years-34.7121.64-160%
Returns for 10 years59.79117.0951%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLNE1.890.02
+1.07%
Clean Energy Fuels Corp
SPMA25.110.14
+0.58%
Sound Point Meridian Capital Inc
NVCR17.49-0.11
-0.63%
NovoCure Limited
R274.66-2.57
-0.93%
Ryder System
CNTX0.66-0.02
-3.31%
Context Therapeutics